medigraphic.com

2019, Number 3

<< Back Next >>

Cir Cir 2019; 87 (3)

Intragastric balloon placement for the management of obesity: improving patient selection

Leyva-Alvizo A, González-Gómez E, Treviño-Garza FX, Espino-Rodríguez M

Language: Spanish
References: 19
Page: 285-291
PDF size: 291.39 Kb.


ABSTRACT

Objective: Review and determination of ideal characteristics for the management of obesity by intragastric balloon, in Monterrey, Mexico. Method: Retrospective analysis of 152 patients, with overweight and obesity from January 2009 to December 2015, to whom an intragastric balloon was placed. Demography, weight loss, decrease in body mass index (BMI) and complications were analyzed. The objective was to determine the group of patients that will benefit the most after endoscopic intragastric balloon placement. Results: A sample of 120 women and 32 men was analyzed. As expected, greater weight loss was observed in patients with BMI › 40 (n = 10, 6.57%, m = 26.29 ± 5.69; p = 0.001) and the lowest in patients with a BMI ‹ 29.9 (n = 24, 15.78 %). Greater satisfaction was detected among patients with an average loss of 15.24 ± 2.75 kg (p ‹ 0.001), and greater indifference among patients with greater losses. There is a tendency among women towards dissatisfaction. Conclusions: The greatest weight loss was observed among patients with a BMI › 40, although the highest satisfaction was observed among men with an average BMI of 32, which is why we recommend the procedure for these patients. We consider it to be an excellent bridge procedure for patients with BMI › 50.


REFERENCES

  1. Evans JD, Scott MH. Intragastric balloon in the treatment of patients with morbid obesity. Br J Surg. 2001;88:1245-8.

  2. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. Geneva: WHO; 2000.

  3. National Institute for Health and Clinical Excellence. Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children. London: National Institute for Health and Clinical Excellence (UK); 2006.

  4. Lau DC, Teoh H. Benefits of modest weight loss on the management of type 2 diabetes mellitus. Can J Diabetes. 2013;37:128-34.

  5. Vilallonga R, Valverde S, Caubet E. Intestinal occlusion as unusual complication of new intragastric balloon Spatz Adjustable Balloon system for treatment of morbid obesity. Surg Obes Relat Dis. 2013;9:e16-7.

  6. Geliebter A. Gastric distension and gastric capacity in relation to food intake in humans. Physiol Behav. 1988;44 665-8.

  7. Su HJ, Kao CH, Chen WC, Chang TT, Lin CY. Effect of intragastric balloon on gastric emptying time in humans for weight control. Clin Nucl Med. 2013;38:863-8.

  8. Bonazzi P, Petrelli MD, Lorenzini I, Peruzzi E, Nicolai A, Galeazzi R. Gastric emptying and intragastric balloon in obese patients. Eur Rev Med Pharmacol Sci. 2005;9(5 Suppl 1):15-21.

  9. Martins Fernandes FA, Carvalho GL, Lima DL, Rao P, Shadduck PP, Montandon ID, et al. Intragastric balloon for overweight patients. JSLS. 2016;20(1). pii: e2015.00107

  10. Göttig S, Weiner RA, Daskalakis M. Preoperative weight reduction using the intragastric balloon. Obes Facts. 2009;2(Suppl 1):20-3.

  11. Spyropoulos C, Katsakoulis E, Mead N, Vagenas K, Kalfarentzos F. Intragastric balloon for high-risk super-obese patients: a prospective analysis of efficacy. Surg Obes Relat Dis. 2007;3:78-83.

  12. Fernandez AZ, Demaria EJ, Tichansky DS, Kellum JM, Wolfe LG, Meador J, et al. Multivariate analysis of risk factors for death following gastric bypass for treatment of morbid obesity. Ann Surg. 2004;239:698-702; discussion 702-3.

  13. Busetto L, Segato G, De Luca M, Bortolozzi E, MacCari T, Magon A, et al. Preoperative weight loss by intragastric balloon in super-obese patients treated with laparoscopic gastric banding: a case-control study. Obes Surg. 2004;14 671-6.

  14. Abu Dayyeh BK, Kumar N, Edmundowicz SA, Jonnalagadda S, Larsen M, Sullivan S, et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015;82:425-38 e5.

  15. Alvarado R, Alami RS, Hsu G, Safadi BY, Sanchez BR, Morton JM, et al. The impact of preoperative weight loss in patients undergoing laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2005;15:1282-6.

  16. Frutos MD, Morales MD, Luján J, Hernández Q, Valero G, Parrilla P. Intragastric balloon reduces liver volume in super-obese patients, facilitating subsequent laparoscopic gastric bypass. Obes Surg. 2007;17:150-4.

  17. Vanden Eynden F, Urbain P. Small intestine gastric balloon impaction treated by laparoscopic surgery. Obes Surg. 2001;11:646-8.

  18. Sallet JA, Marchesini J, Sasllet P. Endoluminal Therapy for The Treatment of Obesity (Intragastric Balloon) Brazilian Multicentric Study Group. Surg Obes Relat Dis. 2015;11:S27-S8.

  19. Dumonceau JM. Evidence-based review of the Bioenterics intragastric balloon for weight loss. Obes Surg. 2008;18:1611-7.




2020     |     www.medigraphic.com